Davinelli, S.; Nicolosi, D.; Di Cesare, C.; Scapagnini, G.; Di Marco, R.
Targeting Metabolic Consequences of Insulin Resistance in Polycystic Ovary Syndrome by D-chiro-inositol and Emerging Nutraceuticals: A Focused Review. J. Clin. Med. 2020, 9, 987.
https://doi.org/10.3390/jcm9040987
AMA Style
Davinelli S, Nicolosi D, Di Cesare C, Scapagnini G, Di Marco R.
Targeting Metabolic Consequences of Insulin Resistance in Polycystic Ovary Syndrome by D-chiro-inositol and Emerging Nutraceuticals: A Focused Review. Journal of Clinical Medicine. 2020; 9(4):987.
https://doi.org/10.3390/jcm9040987
Chicago/Turabian Style
Davinelli, Sergio, Daria Nicolosi, Cinzia Di Cesare, Giovanni Scapagnini, and Roberto Di Marco.
2020. "Targeting Metabolic Consequences of Insulin Resistance in Polycystic Ovary Syndrome by D-chiro-inositol and Emerging Nutraceuticals: A Focused Review" Journal of Clinical Medicine 9, no. 4: 987.
https://doi.org/10.3390/jcm9040987
APA Style
Davinelli, S., Nicolosi, D., Di Cesare, C., Scapagnini, G., & Di Marco, R.
(2020). Targeting Metabolic Consequences of Insulin Resistance in Polycystic Ovary Syndrome by D-chiro-inositol and Emerging Nutraceuticals: A Focused Review. Journal of Clinical Medicine, 9(4), 987.
https://doi.org/10.3390/jcm9040987